Clinical Trial Update: Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia [Phase 2]

View source ↗

Summary

Completed Phase 2 clinical trial update reporting results of a study comparing NXL103 to a comparator in adults with community-acquired pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• NXL103

Snippet

Sponsor: Novexel Inc | Conditions: Community Acquired Pneumonia | Phase 2 | Status: COMPLETED